in vivo

CRISPR Therapeutics

Biotech

CRISPR Tx sees 80% fall in LDL, triglycerides after in vivo edit

CRISPR Tx reported reductions in triglycerides and LDL cholesterol of more than 80% after a single dose of its in vivo liver editing prospect CTX310.

Nick Paul Taylor May 7, 2025 10:00am

Group of scientist or doctors and nurses wearing blue protective gloves putting their hands together

Novartis taps Vyriad’s viral vectors for in vivo T cell editing

Nov 20, 2024 12:00pm

world global globe ex-US country map regions

PharmaLegacy snaps up preclinical CRO

Sep 16, 2024 3:50pm

DNA gene therapy gene editing helix CRISPR

Sanofi, Scribe seal new in vivo collab worth more than $1.2B

Jul 17, 2023 11:30am

Image of a barcode being scanned

George Church-founded biotech tacks on $40M series A

Jul 14, 2022 8:00am

Novartis pays $75M to form sickle cell in vivo gene editing pact

Jun 22, 2022 3:40am